Malignant Pancreatic Neoplasm — Trials

Malignant Pancreatic Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

3,628 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 904
Recruiting: 506
Ph III recruiting: 46
Growth YoY: +21.9%
Industry share: 32%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.5%
Trials / 1,000 deaths: 18.3 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (516)

clinicaltrialsPublishedShowing 251–254 of 254 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04592393	Pancreas Cancer Surveillance Using an Abbreviated MRI	active not recruiting	N/A	200	Seoul National University HospitalOTHER	1	Aug 18, 2023	clinicaltrials
NCT03347162	Muscle Dysfunction in Gastrointestinal or Hepatobiliary Cancer	active not recruiting	—	1,000	Rigshospitalet, DenmarkOTHER	1	Jun 22, 2023	clinicaltrials